Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Abbott recalls infant formula

This article was originally published in The Tan Sheet

Executive Summary

Abbott's Ross Products Division announces Sept. 15 it is voluntarily recalling some lots of liquid ready-to-feed infant formula distributed between May 18 and Sept. 5. One lot of Similac Alimentum Advance liquid ready-to-feed infant formula, use by May 1, 2007; two lots of Similac Advance with Iron liquid ready-to-feed infant formula, use by Nov. 1, 2007; and one lot of Similac Advance Hospital Discharge Kits are all being recalled due to an isolated bottle defect the release states. An Abbott spokesperson said some of the bottles are missing a layer that prevents air from getting to the formula and thus may lead the vitamin C to oxidize, or breakdown. If consumers have the listed products they should contact Abbott at 1-800-624-3412. Abbott discovered the problem as a result of consumer complaints for an unusually dark formula color the release states...

You may also be interested in...

UK IVDs Firms Working Flat Out On COVID-19 Tests, As Govt Promises Test Capacity Increase

Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.

Coronavirus Update: Novartis Targets COVID-19 Cytokine Storm With Jakavi

Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients

As China Rushes Medical Supplies To World, Quality Issues Resurface

As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts